Annette Tumolo - 03 Sep 2021 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
Executive Vice President
Signature
/s/ Annette Tumolo
Issuer symbol
BIO
Transactions as of
03 Sep 2021
Net transactions value
-$695,106
Form type
4
Filing time
08 Sep 2021, 12:06:43 UTC
Previous filing
03 Sep 2021
Next filing
09 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +557 +16% $0.000000 3,939 03 Sep 2021 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability $206,564 -252 -6.4% $819.70 3,687 03 Sep 2021 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +600 +16% $0.000000 4,287 04 Sep 2021 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability $244,271 -298 -7% $819.70 3,989 04 Sep 2021 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +600 +15% $0.000000 4,589 05 Sep 2021 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability $244,271 -298 -6.5% $819.70 4,291 05 Sep 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO Restricted Stock Units Options Exercise $0 -557 -25% $0.000000 1,671 03 Sep 2021 Bio-Rad A Common Stock 557 $0.000000 Direct F2, F3
transaction BIO Restricted Stock Units Options Exercise $0 -600 -33% $0.000000 1,200 04 Sep 2021 Bio-Rad A Common Stock 600 $0.000000 Direct F2, F4
transaction BIO Restricted Stock Units Options Exercise $0 -600 -50% $0.000000 600 05 Sep 2021 Bio-Rad A Common Stock 600 $0.000000 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3 On September 3, 2019, the reporting person was granted 2,784 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.
F4 On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.
F5 On September 5, 2017, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.